NeucaWAR:NEU +0.42%98 Dividend Yield % is 2.23% as of Jun. 26, 2026, which is 27% above its 10-year median of 1.76. GuruFocus rates WAR:NEU with a GF Score™ of 98/100 and a GF Value™ of zł888.72 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 69 Medical Distribution companies, Neuca ranks worse than 60.87% on this metric.
As of today (2026-06-26), the Trailing Annual Dividend Yield of Neuca is 2.23%.
The historical rank and industry rank for Neuca's Dividend Yield % or its related term are showing as below:
WAR:NEU'
s Dividend Yield % Range Over the Past 10 Years
Min: 1.05 Med: 1.76 Max: 3.43
Current: 2.23
During the past 13 years, the highest Dividend Yield of Neuca was 3.43%. The lowest was 1.05%. And the median was 1.76%.
WAR:NEU's Dividend Yield % is ranked worse than 60.87% of 69
companies
in the Medical Distribution industry
Industry Median: 2.89
vs WAR:NEU: 2.23
During the past 12 months, Neuca's average Dividends Per Share Growth Rate was 10.30% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 11.60% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 13.10% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 14.30% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Neuca was 22.80% per year. The lowest was 11.60% per year. And the median was 15.30% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Neuca (WAR:NEU) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Neuca's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:NEU vs MCK, COR, CAH: Dividend Yield % Comparison
For the Medical Distribution subindustry, Neuca's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neuca Dividend Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Neuca's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Neuca's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Neuca Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
PLN 16.000000
2025-07-15
2025-07-16
2025-07-28
Cash Dividend
annually
PLN:PLN 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Neuca's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
16
/
717.00
=
2.23 %
Current Share Price is zł717.00. Neuca's Dividends per Share for the trailing twelve months (TTM) ended in Today is zł16.
Neuca's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
16
/
717.00
=
2.23 %
Current Share Price is zł717.00. Neuca's Dividends per Share for the forward twelve months is calculated as zł16 * 1 = zł16.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neuca (WAR:NEU) has a Dividend Yield % of 2.23% as of Jun. 26, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Neuca and its competitors. This is 27% above median its historical median of 1.76. Over the past decade, Neuca's Dividend Yield % has ranged from 1.05 to 3.43. According to the industry distribution chart, Neuca ranks #42 out of 69 companies in the Medical Distribution industry, placing it in the top 60.9%.
Is Neuca's Dividend Yield % too high?
Neuca's current Dividend Yield % of 2.23% is 27% above median its 10-year median of 1.76. Over the past 10 years, this metric has ranged from a low of 1.05 to a high of 3.43. The Medical Distribution industry median Dividend Yield % is 2.89. Neuca's value of 2.23% is 22.8% below this industry median. Based on the distribution chart, Neuca ranks #42 out of 69 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Neuca has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neuca's Dividend Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Neuca ranks #42 out of 69 companies for Dividend Yield %. This places Neuca in the lower half of its industry. The industry median Dividend Yield % is 2.89. Neuca's value of 2.23% is 22.8% below this benchmark. Historically, Neuca's own Dividend Yield % has ranged from 1.05 to 3.43 over the past decade. While the company's 10-year median is 1.76 vs. the industry median of 2.89, Neuca has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Distribution company?
The median Dividend Yield % among Medical Distribution companies is 2.89, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neuca's current Dividend Yield % of 2.23% is 22.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Neuca and its competitors. For the Medical Distribution industry, the median Dividend Yield % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neuca's current Dividend Yield % is 2.23%, which is 27% above median its own 10-year median of 1.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuca stock overvalued right now?
Based on GuruFocus' analysis, Neuca (WAR:NEU) is currently considered Modestly Undervalued. The stock's GF Value™ is zł888.72, compared to a current price of zł717.00 — trading 19.3% below its estimated fair value. The current Dividend Yield % is 2.23%, which is 27% above median its 10-year median of 1.76 and 22.8% below the Medical Distribution industry median of 2.89. Neuca's overall GF Score™ is 98/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Neuca (WAR:NEU), the current Dividend Yield % is 2.23% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neuca (WAR:NEU) Overvalued in 2026?
Based on GuruFocus' analysis, Neuca stock appears to be undervalued.
The current stock price of zł717.00 is trading 19.3% below its estimated GF Value™ of zł888.72.
GuruFocus considers Neuca to be Modestly Undervalued.
Key valuation signals for WAR:NEU:
Dividend Yield %: 2.23% (27% above median its 10-year median of 1.76)
GF Value™: zł888.72 vs. price of zł717.00 (19.3% below fair value)
Industry Position: 22.8% below the Medical Distribution median (#42 of 69)
No single metric tells the full story. See the WAR:NEU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neuca SA is a wholesale distributor of pharmaceuticals in Poland. The company's segment includes Pharmacy wholesale; Manufacture of pharmaceuticals; Outpatient medical care clinics; Clinical trials and Insurance activities. It generates maximum revenue from the Pharmacy wholesale segment.
98GF Score
Get the complete analysis for WAR:NEU
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:NEU has been successfully added to your 
